<DOC>
	<DOCNO>NCT00913653</DOCNO>
	<brief_summary>This study assess safety/tolerability , PK/PD LCZ696 patient stable heart failure .</brief_summary>
	<brief_title>Safety/Tolerability , Pharmacokinetics/Pharmacodynamics ( PK/PD ) LCZ696 Patients With Stable Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>LCZ 696</mesh_term>
	<criteria>Patients document heart failure ( NYHA class IIIV ) Use ACEi ARB , ACEi DRI , ARB DRI treatment , three medication Screening</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Heart failure</keyword>
	<keyword>LCZ696</keyword>
</DOC>